About this trial
This study is a single-blinded (outcome assessor) and parallel-group non-inferiority RCT. Chinese older adults aged ≥60 years with chronic primary insomnia will be randomized evenly (1:1) to either the brisk walking training group or the CBT-I group. Participants in the brisk walking training group receive an eight-week instructor-led interval brisk walking training (40 minutes/session, three sessions/week). Participants in the CBT-I group receive standard-of-care group-based eight-session CBT-I (one session/week). Self-reported and objective sleep outcomes are measured at baseline (T0), after completion of the intervention (T1), and six (T2), and 12 months after T1 (T3).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged ≥60 years;
Ethnic Chinese; able to read, write and speak Cantonese
Having a Hong Kong ID;
Willing to wear an accelerometer on the wrist for a week to assess sleep parameters at T0, T1, and T2.
Disqualifiers
Score ≥1 in the Chinese version of the Physical Activity Readiness Questionnaire (PAR-Q);
Currently regularly practicing a moderate-intensity PA program such as brisk walking or Tai Chi (≥3 times a week, ≥30 minutes/session);
Currently receiving or scheduled to receive CBT-I during the study period;
Score ≤16 in the validated telephone version of the Cantonese Mini-Mental State Examination (T-CMMSE).
Trial design
Parallel
Treatments tested in this trial
Brisk walking
BehavioralParticipants in the brisk walking training group receive an eight-week instructor-led interval brisk walking training (40 minutes/session, three sessions/week).
Cognitive-behavioral therapy for insomnia
BehavioralParticipants in the CBT-I group receive standard-of-care group-based eight-session CBT-I (one session/week).
Treatment groups
Trial outcomes
Primary outcomes
Score of the Insomnia Severity Index (ISI)
Score of the Insomnia Severity Index (ISI) measured at at baseline (T0), after completion of the intervention (T1), and six (T2), and 12 months after T1 (T3).
Secondary outcomes
Insomnia remission
Structured clinical interview to confirm insomnia remission based on the DSM-5 criteria at 12 months after completion of the intervention
Sleep quality
Sleep quality will be measured by the 19-item Pittsburg Sleep Quality Index (PSQI) at baseline (T0), after completion of the intervention (T1), and six (T2), and 12 months after T1 (T3)
Seven-day ActiGraph
Seven-day ActiGraph at baseline (T0), after completion of the intervention (T1), and six (T2), and 12 months after T1 (T3)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: